AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector 
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds 
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
Middle East Conflict Impacts Australia and New Zealand Businesses 
BUENA, N.J., May 07, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care Conference. The Conference is taking place May 8-9, 2018 at the Intercontinental Hotel, Boston.
Damian Finio, Chief Financial Officer of Teligent, Inc., will present on Tuesday, May 8th at 2:10 p.m. ET.
The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com
